Hesperos
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12501 Research Pkwy Ste 100, Orlando, Fl...Phone Number
(407) 900-5915Website
www.hesperosinc.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Hesperos
Hesperos, Inc. is a leader in efforts to characterize an individual's biology with Human-on-a-Chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organ systems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational PKPD modeling of live physiological responses utilizing functional readouts from neurons, cardiac, muscle, barrier tissues and neuromuscular junctions as well as responses from liver, pancreas and barrier tissues.Explore more
Hesperos Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hesperos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Hesperos recently announced quarterly report
Check if Hesperos has recently received funding, and reach out quickly before it becomes old news!
Check out if Hesperos is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Hesperos has new funding data
Hesperos, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Hesperos had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Hesperos launches new products
Congratulate Masked Content for being promoted to Masked Content at Hesperos
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Hesperos
Compare insights from companies similar to Hesperos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Hesperos is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Hesperos is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Hesperos.
Hesperos financials insights
Gather financial insights about Hesperos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$85K
Hesperos Tech Stack
A closer look at the technologies used by Hesperos
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
New Hire
Executive Move
Executive Moves, New Hire
Event
Events
New Hire
Executive Move
Executive Moves, New Hire
Hesperos News & Media
Hesperos Wins ACC.25 Pitch Competition as FDA Unveils Plan to Move Beyond Animal Testing
ORLANDO, Fla.--(BUSINESS WIRE)-- #BiotechNews--Hesperos wins ACC.25 Pitch, showcasing how its Human-on-a-Chip® is accelerating drug development and reducing reliance on animal testing.Hesperos and UCF Researchers Develop Human-on-a-Chip® Platform to Address Opioid Crisis
ORLANDO, Fla.--(BUSINESS WIRE)-- #HEAL--Hesperos and UCF Researchers Develop Human-on-a-Chip® Platform to Address Opioid CrisisHesperos and UCF Researchers Develop Human iPSC-Derived Myelination Model, Enabling Investigation and Treatment Development for Peripheral Nervous System Diseases
ORLANDO, Fla.--(BUSINESS WIRE)-- #ACSBiomaterials--Researchers developed an iPSC-derived peripheral myelination model, advancing research into rare diseases impacting the PNS and potential treatments.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hesperos
Sign Up For FreeTo access detailed company insights
Hesperos, Inc. is a leader in efforts to characterize an individual's biology with Human-on-a-Chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organ systems. Wit... Read More
